Yersinia pestis Versus Yersinia pseudotuberculosis: Effects on Host Macrophages

Scandinavian Journal of Immunology

Volumn 76, Issue 6, 2012, Pages 541-551

  Bi, Y ^a   Wang, X ^a   Han, Y ^a   Guo, Z ^a   Yang, R ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CASPASE 3; INTERLEUKIN 10; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL FUNCTION; CELL POLARITY; CYTOKINE RELEASE; ENZYME ACTIVITY; HOST CELL; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLAGUE; PRIORITY JOURNAL; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; GENETIC SPECIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; PLAGUE; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84869019093     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02767.x     Document Type: Article

References (49)

1. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 1999;96:14043-8.
2. Morelli G, Song Y, Mazzoni CJ et al. Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 2010;42:1140-3.
3. Chain PS, Carniel E, Larimer FW et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 2004;101:13826-31.
4. Song Y, Tong Z, Wang J et al. Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res 2004;11:179-97.
5. Bergsbaken T, Cookson BT. Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation. J Leukoc Biol 2009;86:1153-8.
6. Stenseth NC, Atshabar BB, Begon M et al. Plague: past, present, and future. PLoS Med 2008;5:e3.
7. Erickson DL, Jarrett CO, Wren BW, Hinnebusch BJ. Serotype differences and lack of biofilm formation characterize Yersinia pseudotuberculosis infection of the Xenopsylla cheopis flea vector of Yersinia pestis. J Bacteriol 2006;188:1113-9.
8. Perry RD, Fetherston JD. Yersinia pestis- etiologic agent of plague. Clin Microbiol Rev 1997;10:35-66.
9. Carniel E. Plasmids and pathogenicity islands of Yersinia. Curr Top Microbiol Immunol 2002;264:89-108.
10. Haiko J, Suomalainen M, Ojala T, Lahteenmaki K, Korhonen TK. Invited review: Breaking barriers - attack on innate immune defences by omptin surface proteases of enterobacterial pathogens (Translated from eng). Innate Immun 2009;15:67-80 (in eng).
11. Parkhill J, Wren BW, Thomson NR et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001;413:523-7.
12. Deng W, Burland V, Plunkett G et al. Genome sequence of Yersinia pestis KIM. J Bacteriol 2002;184:4601-11.
13. Hinchliffe SJ, Isherwood KE, Stabler RA et al. Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. Genome Res 2003;13:2018-29.
14. Stabler RA, Hinds J, Witney AA et al. Construction of a Yersinia pestis microarray. Adv Exp Med Biol 2003;529:47-9.
15. Achtman M. Population structure of pathogenic bacteria revisited. Int J Med Microbiol 2004;294:67-73.
16. Chain PS, Hu P, Malfatti SA et al. Complete genome sequence of Yersinia pestis strains Antiqua and Nepal516: evidence of gene reduction in an emerging pathogen. J Bacteriol 2006;188:4453-63.
17. Chromy BA, Perkins J, Heidbrink JL et al. Proteomic characterization of host response to Yersinia pestis and near neighbors. Biochem Biophys Res Commun 2004;320:474-9.
18. Zhang CG, Gonzales AD, Choi MW, Chromy BA, Fitch JP, McCutchen-Maloney SL. Subcellular proteomic analysis of host-pathogen interactions using human monocytes exposed to Yersinia pestis and Yersinia pseudotuberculosis. Proteomics 2005;5:1877-88.
19. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. Plague bacteria target immune cells during infection. Science 2005;309:1739-41.
20. Pujol C, Bliska JB. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin Immunol 2005;114:216-26.
21. Zhou D, Tong Z, Song Y et al. Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol 2004;186:5147-52.
22. Skurnik M, Peippo A, Ervela E. Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b. Mol Microbiol 2000;37:316-30.
23. Celada A, Gray PW, Rinderknecht E, Schreiber RD. Evidence for a γ-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med 1984;160:55-74.
24. + macrophages. J Cell Physiol 2006;209:341-52.
25. Bi Y, Du Z, Yang H et al. Reduced apoptosis of mouse macrophages induced by yscW mutant of Yersinia pestis results from the reduced secretion of YopJ and relates to caspase-3 signal pathway. Scand J Immunol 2009;70:358-67.
26. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok J, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Ann Biochem 1982;126:131-8.
27. Corraliza IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994;174:231-5.
28. Ruckdeschel K. Immunomodulation of macrophages by pathogenic Yersinia species. Arch Immunol Ther Exp (Warsz) 2002;50:131-7.
29. Boland A, Cornelis GR. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun 1998;66:1878-84.
30. Zakharova M, Ziegler HK. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J Immunol 2005;175:5024-33.
31. Radnedge L, Agron PG, Worsham PL, Andersen GL. Genome plasticity in Yersinia pestis. Microbiology 2002;148 (Pt 6):1687-98.
32. Zhou D, Han Y, Song Y et al. DNA microarray analysis of genome dynamics in Yersinia pestis: insights into bacterial genome microevolution and niche adaptation. J Bacteriol 2004;186:5138-46.
33. Zhang Y, Bliska JB. Role of macrophage apoptosis in the pathogenesis of Yersinia. Curr Top Microbiol Immunol 2005;289:151-73.
34. Zauberman A, Cohen S, Mamroud E et al. Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 2006;74:3239-50.
35. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun 1986;51:445-54.
36. Monack DM, Mecsas J, Bouley D, Falkow S. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 1998;188:2127-37.
37. Lien E, Means TK, Heine H et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000;105:497-504.
38. Montminy SW, Khan N, McGrath S et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 2006;7:1066-73.
39. Heesemann J, Sing A, Trulzsch K. Yersinia's stratagem: targeting innate and adaptive immune defense. Curr Opin Microbiol 2006;9:55-61.
40. Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 2005;59:69-89.
41. Cornelis GR. Molecular and cell biology aspects of plague. Proc Natl Acad Sci USA 2000;97:8778-83.
42. Du Y, Rosqvist R, Forsberg A. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 2002;70:1453-60.
43. Huang X-Z, Lindler LE. The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen. Infect Immun 2004;72:7212-9.
44. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
45. Vazquez-Torres A, Xu Y, Jones-Carson J et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 2000;287:1655-8.
46. Miller BH, Fratti RA, Poschet JF et al. Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect Immun 2004;72:2872-8.
47. Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka AK. TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol 2003;171:2262-9.
48. Troelstra A, de Graaf-Miltenburg LA, van Bommel T et al. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18. J Immunol 1999;162:4220-5.
49. Raychaudhuri B, Fisher CJ, Farver CF et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine 2000;12:1348-55.